{"doi":"10.1007/s00148-025-01111-5","title":"Fighting abuse with prescription tracking: mandatory drug monitoring and intimate partner violence","abstract":"The opioid crisis generates broader societal harms beyond direct health and economic effects, impacting non-users through adverse spillovers on children, families, and communities. We study the spillover effects of a supply-side policy aimed at reducing overprescription of opioids on women's well-being by examining its effects on intimate partner violence (IPV) in the United States. Using administrative data on incidents reported to law enforcement, in conjunction with quasi-experimental variation in the adoption of stringent mandatory-access prescription drug monitoring programs, we find that these policies generate a downstream benefit for women by significantly reducing their overall exposure to IPV and IPV-involved injuries by 9 to 10%. The strongest effects are experienced by groups with higher rates of opioid consumption at baseline, including non-Hispanic Whites. Our findings also show a significant increase in heroin-involved IPV incidents, suggesting substitution into illicit drug consumption. However, since heroin-related IPV accounts for less than 1% of all incidents, its increase among highly opioid-dependent individuals does not offset the overall decline in total IPV incidents in affected states. Our results highlight the need to identify high-risk groups prone to switching to illicit opioids and to address this risk through evidence-based policies. Supplementary Information: The online version contains supplementary material available at 10.1007/s00148-025-01111-5.","journal":"Journal of Population Economics","year":2025,"id":539669,"datarank":0.20794415416798362,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.0,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9568,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1427211,"name":"Bilge Erten","orcid":"0000-0002-3142-8072","position":1,"is_corresponding":false},{"id":1427604,"name":"David Hummel","orcid":null,"position":2,"is_corresponding":false},{"id":1427212,"name":"Pinar Keskin","orcid":"0000-0002-9788-787X","position":3,"is_corresponding":false},{"id":1427213,"name":"Shuo Zhang","orcid":"0000-0002-3489-5290","position":4,"is_corresponding":false},{"id":563409,"name":"Dhaval Dave","orcid":"0000-0003-4514-3761","position":0,"is_corresponding":true}],"reference_count":73,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:52:34.520788Z","pmid":"40589851","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}